Global Ulcerative Colitis Immunology Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Ulcerative Colitis Immunology Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Ulcerative Colitis Immunology Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Ulcerative Colitis Immunology Drugs by Country/Region, 2017, 2022 & 2028

2.2 Ulcerative Colitis Immunology Drugs Segment by Type

2.2.1 Adalimumab

2.2.2 Certolizumab Pegol

2.2.3 Tofacitinib

2.2.4 Etanercept

2.2.5 Golimumab

2.2.6 Abatacept

2.2.7 Infliximab

2.2.8 Others

2.3 Ulcerative Colitis Immunology Drugs Sales by Type

2.3.1 Global Ulcerative Colitis Immunology Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Ulcerative Colitis Immunology Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Ulcerative Colitis Immunology Drugs Sale Price by Type (2017-2022)

2.4 Ulcerative Colitis Immunology Drugs Segment by Application

2.4.1 Rheumatoid Arthritis

2.4.2 Crohn's Disease(CD)

2.4.3 Ankylosing Spondylitis(AS)

2.4.4 Psoriasis(Ps)

2.4.5 Ulcerative Colitis(UC)

2.5 Ulcerative Colitis Immunology Drugs Sales by Application

2.5.1 Global Ulcerative Colitis Immunology Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Ulcerative Colitis Immunology Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Ulcerative Colitis Immunology Drugs Sale Price by Application (2017-2022)

3 Global Ulcerative Colitis Immunology Drugs by Company

3.1 Global Ulcerative Colitis Immunology Drugs Breakdown Data by Company

3.1.1 Global Ulcerative Colitis Immunology Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Ulcerative Colitis Immunology Drugs Sales Market Share by Company (2020-2022)

3.2 Global Ulcerative Colitis Immunology Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Ulcerative Colitis Immunology Drugs Revenue by Company (2020-2022)

3.2.2 Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Ulcerative Colitis Immunology Drugs Sale Price by Company

3.4 Key Manufacturers Ulcerative Colitis Immunology Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Ulcerative Colitis Immunology Drugs Product Location Distribution

3.4.2 Players Ulcerative Colitis Immunology Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Ulcerative Colitis Immunology Drugs by Geographic Region

4.1 World Historic Ulcerative Colitis Immunology Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Ulcerative Colitis Immunology Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Ulcerative Colitis Immunology Drugs Annual Revenue by Geographic Region

4.2 World Historic Ulcerative Colitis Immunology Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Ulcerative Colitis Immunology Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Ulcerative Colitis Immunology Drugs Annual Revenue by Country/Region

4.3 Americas Ulcerative Colitis Immunology Drugs Sales Growth

4.4 APAC Ulcerative Colitis Immunology Drugs Sales Growth

4.5 Europe Ulcerative Colitis Immunology Drugs Sales Growth

4.6 Middle East & Africa Ulcerative Colitis Immunology Drugs Sales Growth

5 Americas

5.1 Americas Ulcerative Colitis Immunology Drugs Sales by Country

5.1.1 Americas Ulcerative Colitis Immunology Drugs Sales by Country (2017-2022)

5.1.2 Americas Ulcerative Colitis Immunology Drugs Revenue by Country (2017-2022)

5.2 Americas Ulcerative Colitis Immunology Drugs Sales by Type

5.3 Americas Ulcerative Colitis Immunology Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Ulcerative Colitis Immunology Drugs Sales by Region

6.1.1 APAC Ulcerative Colitis Immunology Drugs Sales by Region (2017-2022)

6.1.2 APAC Ulcerative Colitis Immunology Drugs Revenue by Region (2017-2022)

6.2 APAC Ulcerative Colitis Immunology Drugs Sales by Type

6.3 APAC Ulcerative Colitis Immunology Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Ulcerative Colitis Immunology Drugs by Country

7.1.1 Europe Ulcerative Colitis Immunology Drugs Sales by Country (2017-2022)

7.1.2 Europe Ulcerative Colitis Immunology Drugs Revenue by Country (2017-2022)

7.2 Europe Ulcerative Colitis Immunology Drugs Sales by Type

7.3 Europe Ulcerative Colitis Immunology Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Ulcerative Colitis Immunology Drugs by Country

8.1.1 Middle East & Africa Ulcerative Colitis Immunology Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Ulcerative Colitis Immunology Drugs Sales by Type

8.3 Middle East & Africa Ulcerative Colitis Immunology Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Ulcerative Colitis Immunology Drugs

10.3 Manufacturing Process Analysis of Ulcerative Colitis Immunology Drugs

10.4 Industry Chain Structure of Ulcerative Colitis Immunology Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Ulcerative Colitis Immunology Drugs Distributors

11.3 Ulcerative Colitis Immunology Drugs Customer

12 World Forecast Review for Ulcerative Colitis Immunology Drugs by Geographic Region

12.1 Global Ulcerative Colitis Immunology Drugs Market Size Forecast by Region

12.1.1 Global Ulcerative Colitis Immunology Drugs Forecast by Region (2023-2028)

12.1.2 Global Ulcerative Colitis Immunology Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Ulcerative Colitis Immunology Drugs Forecast by Type

12.7 Global Ulcerative Colitis Immunology Drugs Forecast by Application

13 Key Players Analysis

13.1 Janssen Biotech, Inc.

13.1.1 Janssen Biotech, Inc. Company Information

13.1.2 Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Product Offered

13.1.3 Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Janssen Biotech, Inc. Main Business Overview

13.1.5 Janssen Biotech, Inc. Latest Developments

13.2 Bristol-Myers Squibb Company

13.2.1 Bristol-Myers Squibb Company Company Information

13.2.2 Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Product Offered

13.2.3 Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bristol-Myers Squibb Company Main Business Overview

13.2.5 Bristol-Myers Squibb Company Latest Developments

13.3 AbbVie Inc.

13.3.1 AbbVie Inc. Company Information

13.3.2 AbbVie Inc. Ulcerative Colitis Immunology Drugs Product Offered

13.3.3 AbbVie Inc. Ulcerative Colitis Immunology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 AbbVie Inc. Main Business Overview

13.3.5 AbbVie Inc. Latest Developments

13.4 UCBCares

13.4.1 UCBCares Company Information

13.4.2 UCBCares Ulcerative Colitis Immunology Drugs Product Offered

13.4.3 UCBCares Ulcerative Colitis Immunology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 UCBCares Main Business Overview

13.4.5 UCBCares Latest Developments

13.5 AMGEN

13.5.1 AMGEN Company Information

13.5.2 AMGEN Ulcerative Colitis Immunology Drugs Product Offered

13.5.3 AMGEN Ulcerative Colitis Immunology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AMGEN Main Business Overview

13.5.5 AMGEN Latest Developments

13.6 Celltrion Healthcare

13.6.1 Celltrion Healthcare Company Information

13.6.2 Celltrion Healthcare Ulcerative Colitis Immunology Drugs Product Offered

13.6.3 Celltrion Healthcare Ulcerative Colitis Immunology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Celltrion Healthcare Main Business Overview

13.6.5 Celltrion Healthcare Latest Developments

13.7 Biogen

13.7.1 Biogen Company Information

13.7.2 Biogen Ulcerative Colitis Immunology Drugs Product Offered

13.7.3 Biogen Ulcerative Colitis Immunology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Biogen Main Business Overview

13.7.5 Biogen Latest Developments

13.8 Genentech USA, Inc.

13.8.1 Genentech USA, Inc. Company Information

13.8.2 Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Product Offered

13.8.3 Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Genentech USA, Inc. Main Business Overview

13.8.5 Genentech USA, Inc. Latest Developments

13.9 ROCHE

13.9.1 ROCHE Company Information

13.9.2 ROCHE Ulcerative Colitis Immunology Drugs Product Offered

13.9.3 ROCHE Ulcerative Colitis Immunology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 ROCHE Main Business Overview

13.9.5 ROCHE Latest Developments

13.10 Pfizer Inc.

13.10.1 Pfizer Inc. Company Information

13.10.2 Pfizer Inc. Ulcerative Colitis Immunology Drugs Product Offered

13.10.3 Pfizer Inc. Ulcerative Colitis Immunology Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Pfizer Inc. Main Business Overview

13.10.5 Pfizer Inc. Latest Developments

14 Research Findings and Conclusion

Table 1. Ulcerative Colitis Immunology Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Ulcerative Colitis Immunology Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Adalimumab

Table 4. Major Players of Certolizumab Pegol

Table 5. Major Players of Tofacitinib

Table 6. Major Players of Etanercept

Table 7. Major Players of Golimumab

Table 8. Major Players of Abatacept

Table 9. Major Players of Infliximab

Table 10. Major Players of Others

Table 11. Global Ulcerative Colitis Immunology Drugs Sales by Type (2017-2022) & (K Pcs)

Table 12. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Type (2017-2022)

Table 13. Global Ulcerative Colitis Immunology Drugs Revenue by Type (2017-2022) & ($ million)

Table 14. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Type (2017-2022)

Table 15. Global Ulcerative Colitis Immunology Drugs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 16. Global Ulcerative Colitis Immunology Drugs Sales by Application (2017-2022) & (K Pcs)

Table 17. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Application (2017-2022)

Table 18. Global Ulcerative Colitis Immunology Drugs Revenue by Application (2017-2022)

Table 19. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Application (2017-2022)

Table 20. Global Ulcerative Colitis Immunology Drugs Sale Price by Application (2017-2022) & (USD/Pcs)

Table 21. Global Ulcerative Colitis Immunology Drugs Sales by Company (2020-2022) & (K Pcs)

Table 22. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Company (2020-2022)

Table 23. Global Ulcerative Colitis Immunology Drugs Revenue by Company (2020-2022) ($ Millions)

Table 24. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Company (2020-2022)

Table 25. Global Ulcerative Colitis Immunology Drugs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 26. Key Manufacturers Ulcerative Colitis Immunology Drugs Producing Area Distribution and Sales Area

Table 27. Players Ulcerative Colitis Immunology Drugs Products Offered

Table 28. Ulcerative Colitis Immunology Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 29. New Products and Potential Entrants

Table 30. Mergers & Acquisitions, Expansion

Table 31. Global Ulcerative Colitis Immunology Drugs Sales by Geographic Region (2017-2022) & (K Pcs)

Table 32. Global Ulcerative Colitis Immunology Drugs Sales Market Share Geographic Region (2017-2022)

Table 33. Global Ulcerative Colitis Immunology Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 34. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 35. Global Ulcerative Colitis Immunology Drugs Sales by Country/Region (2017-2022) & (K Pcs)

Table 36. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Country/Region (2017-2022)

Table 37. Global Ulcerative Colitis Immunology Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 38. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Country/Region (2017-2022)

Table 39. Americas Ulcerative Colitis Immunology Drugs Sales by Country (2017-2022) & (K Pcs)

Table 40. Americas Ulcerative Colitis Immunology Drugs Sales Market Share by Country (2017-2022)

Table 41. Americas Ulcerative Colitis Immunology Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 42. Americas Ulcerative Colitis Immunology Drugs Revenue Market Share by Country (2017-2022)

Table 43. Americas Ulcerative Colitis Immunology Drugs Sales by Type (2017-2022) & (K Pcs)

Table 44. Americas Ulcerative Colitis Immunology Drugs Sales Market Share by Type (2017-2022)

Table 45. Americas Ulcerative Colitis Immunology Drugs Sales by Application (2017-2022) & (K Pcs)

Table 46. Americas Ulcerative Colitis Immunology Drugs Sales Market Share by Application (2017-2022)

Table 47. APAC Ulcerative Colitis Immunology Drugs Sales by Region (2017-2022) & (K Pcs)

Table 48. APAC Ulcerative Colitis Immunology Drugs Sales Market Share by Region (2017-2022)

Table 49. APAC Ulcerative Colitis Immunology Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 50. APAC Ulcerative Colitis Immunology Drugs Revenue Market Share by Region (2017-2022)

Table 51. APAC Ulcerative Colitis Immunology Drugs Sales by Type (2017-2022) & (K Pcs)

Table 52. APAC Ulcerative Colitis Immunology Drugs Sales Market Share by Type (2017-2022)

Table 53. APAC Ulcerative Colitis Immunology Drugs Sales by Application (2017-2022) & (K Pcs)

Table 54. APAC Ulcerative Colitis Immunology Drugs Sales Market Share by Application (2017-2022)

Table 55. Europe Ulcerative Colitis Immunology Drugs Sales by Country (2017-2022) & (K Pcs)

Table 56. Europe Ulcerative Colitis Immunology Drugs Sales Market Share by Country (2017-2022)

Table 57. Europe Ulcerative Colitis Immunology Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 58. Europe Ulcerative Colitis Immunology Drugs Revenue Market Share by Country (2017-2022)

Table 59. Europe Ulcerative Colitis Immunology Drugs Sales by Type (2017-2022) & (K Pcs)

Table 60. Europe Ulcerative Colitis Immunology Drugs Sales Market Share by Type (2017-2022)

Table 61. Europe Ulcerative Colitis Immunology Drugs Sales by Application (2017-2022) & (K Pcs)

Table 62. Europe Ulcerative Colitis Immunology Drugs Sales Market Share by Application (2017-2022)

Table 63. Middle East & Africa Ulcerative Colitis Immunology Drugs Sales by Country (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Ulcerative Colitis Immunology Drugs Sales Market Share by Country (2017-2022)

Table 65. Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 66. Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue Market Share by Country (2017-2022)

Table 67. Middle East & Africa Ulcerative Colitis Immunology Drugs Sales by Type (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Ulcerative Colitis Immunology Drugs Sales Market Share by Type (2017-2022)

Table 69. Middle East & Africa Ulcerative Colitis Immunology Drugs Sales by Application (2017-2022) & (K Pcs)

Table 70. Middle East & Africa Ulcerative Colitis Immunology Drugs Sales Market Share by Application (2017-2022)

Table 71. Key Market Drivers & Growth Opportunities of Ulcerative Colitis Immunology Drugs

Table 72. Key Market Challenges & Risks of Ulcerative Colitis Immunology Drugs

Table 73. Key Industry Trends of Ulcerative Colitis Immunology Drugs

Table 74. Ulcerative Colitis Immunology Drugs Raw Material

Table 75. Key Suppliers of Raw Materials

Table 76. Ulcerative Colitis Immunology Drugs Distributors List

Table 77. Ulcerative Colitis Immunology Drugs Customer List

Table 78. Global Ulcerative Colitis Immunology Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. Global Ulcerative Colitis Immunology Drugs Sales Market Forecast by Region

Table 80. Global Ulcerative Colitis Immunology Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Global Ulcerative Colitis Immunology Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 82. Americas Ulcerative Colitis Immunology Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Americas Ulcerative Colitis Immunology Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. APAC Ulcerative Colitis Immunology Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 85. APAC Ulcerative Colitis Immunology Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 86. Europe Ulcerative Colitis Immunology Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Europe Ulcerative Colitis Immunology Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Middle East & Africa Ulcerative Colitis Immunology Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 89. Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 90. Global Ulcerative Colitis Immunology Drugs Sales Forecast by Type (2023-2028) & (K Pcs)

Table 91. Global Ulcerative Colitis Immunology Drugs Sales Market Share Forecast by Type (2023-2028)

Table 92. Global Ulcerative Colitis Immunology Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 93. Global Ulcerative Colitis Immunology Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 94. Global Ulcerative Colitis Immunology Drugs Sales Forecast by Application (2023-2028) & (K Pcs)

Table 95. Global Ulcerative Colitis Immunology Drugs Sales Market Share Forecast by Application (2023-2028)

Table 96. Global Ulcerative Colitis Immunology Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 97. Global Ulcerative Colitis Immunology Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 98. Janssen Biotech, Inc. Basic Information, Ulcerative Colitis Immunology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 99. Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Product Offered

Table 100. Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. Janssen Biotech, Inc. Main Business

Table 102. Janssen Biotech, Inc. Latest Developments

Table 103. Bristol-Myers Squibb Company Basic Information, Ulcerative Colitis Immunology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 104. Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Product Offered

Table 105. Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 106. Bristol-Myers Squibb Company Main Business

Table 107. Bristol-Myers Squibb Company Latest Developments

Table 108. AbbVie Inc. Basic Information, Ulcerative Colitis Immunology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 109. AbbVie Inc. Ulcerative Colitis Immunology Drugs Product Offered

Table 110. AbbVie Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 111. AbbVie Inc. Main Business

Table 112. AbbVie Inc. Latest Developments

Table 113. UCBCares Basic Information, Ulcerative Colitis Immunology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 114. UCBCares Ulcerative Colitis Immunology Drugs Product Offered

Table 115. UCBCares Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 116. UCBCares Main Business

Table 117. UCBCares Latest Developments

Table 118. AMGEN Basic Information, Ulcerative Colitis Immunology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 119. AMGEN Ulcerative Colitis Immunology Drugs Product Offered

Table 120. AMGEN Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 121. AMGEN Main Business

Table 122. AMGEN Latest Developments

Table 123. Celltrion Healthcare Basic Information, Ulcerative Colitis Immunology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 124. Celltrion Healthcare Ulcerative Colitis Immunology Drugs Product Offered

Table 125. Celltrion Healthcare Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 126. Celltrion Healthcare Main Business

Table 127. Celltrion Healthcare Latest Developments

Table 128. Biogen Basic Information, Ulcerative Colitis Immunology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 129. Biogen Ulcerative Colitis Immunology Drugs Product Offered

Table 130. Biogen Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 131. Biogen Main Business

Table 132. Biogen Latest Developments

Table 133. Genentech USA, Inc. Basic Information, Ulcerative Colitis Immunology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 134. Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Product Offered

Table 135. Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 136. Genentech USA, Inc. Main Business

Table 137. Genentech USA, Inc. Latest Developments

Table 138. ROCHE Basic Information, Ulcerative Colitis Immunology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 139. ROCHE Ulcerative Colitis Immunology Drugs Product Offered

Table 140. ROCHE Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 141. ROCHE Main Business

Table 142. ROCHE Latest Developments

Table 143. Pfizer Inc. Basic Information, Ulcerative Colitis Immunology Drugs Manufacturing Base, Sales Area and Its Competitors

Table 144. Pfizer Inc. Ulcerative Colitis Immunology Drugs Product Offered

Table 145. Pfizer Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 146. Pfizer Inc. Main Business

Table 147. Pfizer Inc. Latest Developments

List of Figures

Figure 1. Picture of Ulcerative Colitis Immunology Drugs

Figure 2. Ulcerative Colitis Immunology Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Ulcerative Colitis Immunology Drugs Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Ulcerative Colitis Immunology Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Ulcerative Colitis Immunology Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Adalimumab

Figure 10. Product Picture of Certolizumab Pegol

Figure 11. Product Picture of Tofacitinib

Figure 12. Product Picture of Etanercept

Figure 13. Product Picture of Golimumab

Figure 14. Product Picture of Abatacept

Figure 15. Product Picture of Infliximab

Figure 16. Product Picture of Others

Figure 17. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Type in 2021

Figure 18. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Type (2017-2022)

Figure 19. Ulcerative Colitis Immunology Drugs Consumed in Rheumatoid Arthritis

Figure 20. Global Ulcerative Colitis Immunology Drugs Market: Rheumatoid Arthritis (2017-2022) & (K Pcs)

Figure 21. Ulcerative Colitis Immunology Drugs Consumed in Crohn's Disease(CD)

Figure 22. Global Ulcerative Colitis Immunology Drugs Market: Crohn's Disease(CD) (2017-2022) & (K Pcs)

Figure 23. Ulcerative Colitis Immunology Drugs Consumed in Ankylosing Spondylitis(AS)

Figure 24. Global Ulcerative Colitis Immunology Drugs Market: Ankylosing Spondylitis(AS) (2017-2022) & (K Pcs)

Figure 25. Ulcerative Colitis Immunology Drugs Consumed in Psoriasis(Ps)

Figure 26. Global Ulcerative Colitis Immunology Drugs Market: Psoriasis(Ps) (2017-2022) & (K Pcs)

Figure 27. Ulcerative Colitis Immunology Drugs Consumed in Ulcerative Colitis(UC)

Figure 28. Global Ulcerative Colitis Immunology Drugs Market: Ulcerative Colitis(UC) (2017-2022) & (K Pcs)

Figure 29. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Application (2017-2022)

Figure 30. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Application in 2021

Figure 31. Ulcerative Colitis Immunology Drugs Revenue Market by Company in 2021 ($ Million)

Figure 32. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Company in 2021

Figure 33. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 34. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Geographic Region in 2021

Figure 35. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Region (2017-2022)

Figure 36. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Country/Region in 2021

Figure 37. Americas Ulcerative Colitis Immunology Drugs Sales 2017-2022 (K Pcs)

Figure 38. Americas Ulcerative Colitis Immunology Drugs Revenue 2017-2022 ($ Millions)

Figure 39. APAC Ulcerative Colitis Immunology Drugs Sales 2017-2022 (K Pcs)

Figure 40. APAC Ulcerative Colitis Immunology Drugs Revenue 2017-2022 ($ Millions)

Figure 41. Europe Ulcerative Colitis Immunology Drugs Sales 2017-2022 (K Pcs)

Figure 42. Europe Ulcerative Colitis Immunology Drugs Revenue 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Ulcerative Colitis Immunology Drugs Sales 2017-2022 (K Pcs)

Figure 44. Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue 2017-2022 ($ Millions)

Figure 45. Americas Ulcerative Colitis Immunology Drugs Sales Market Share by Country in 2021

Figure 46. Americas Ulcerative Colitis Immunology Drugs Revenue Market Share by Country in 2021

Figure 47. United States Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Canada Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Mexico Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Brazil Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. APAC Ulcerative Colitis Immunology Drugs Sales Market Share by Region in 2021

Figure 52. APAC Ulcerative Colitis Immunology Drugs Revenue Market Share by Regions in 2021

Figure 53. China Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Japan Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. South Korea Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Southeast Asia Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. India Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Australia Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Europe Ulcerative Colitis Immunology Drugs Sales Market Share by Country in 2021

Figure 60. Europe Ulcerative Colitis Immunology Drugs Revenue Market Share by Country in 2021

Figure 61. Germany Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. France Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. UK Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Italy Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Russia Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Middle East & Africa Ulcerative Colitis Immunology Drugs Sales Market Share by Country in 2021

Figure 67. Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue Market Share by Country in 2021

Figure 68. Egypt Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 69. South Africa Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 70. Israel Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 71. Turkey Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 72. GCC Country Ulcerative Colitis Immunology Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 73. Manufacturing Cost Structure Analysis of Ulcerative Colitis Immunology Drugs in 2021

Figure 74. Manufacturing Process Analysis of Ulcerative Colitis Immunology Drugs

Figure 75. Industry Chain Structure of Ulcerative Colitis Immunology Drugs

Figure 76. Channels of Distribution

Figure 77. Distributors Profiles